宫颈癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 宫颈癌（国际通用名 cervical cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖子宫颈癌等说法。

正在招募的宫颈癌新药试验

• HN-QUEST: A Study of Head and Neck Imaging Biomarkers

  不适用招募中加拿大NCT05919290

• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  I 期 / II 期招募中美国Puerto RicoNCT07109726

• Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

  III 期招募中中国NCT05772208

• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

  II 期招募中美国NCT05686226

• Iparomlimab and Tuvonralimab in HNSCC

  II 期招募中中国NCT07090317

• Cancer Genetic Testing in Ethnic Populations

  不适用招募中美国NCT04475640

• Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC

  不适用招募中中国NCT06592755

• mSaada: A Mobile Health Tool

  不适用招募中KenyaNCT05848557

• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

  不适用招募中美国NCT07741968

• Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

  II 期招募中中国NCT07339774

• Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

  不适用招募中英国NCT06440174

• Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

  不适用招募中美国NCT06744296